Relmada Therapeutics, Inc. (RLMD)
NASDAQ: RLMD · Real-Time Price · USD
4.450
+0.020 (0.45%)
At close: Mar 6, 2026, 4:00 PM EST
4.500
+0.050 (1.12%)
After-hours: Mar 6, 2026, 5:51 PM EST
Relmada Therapeutics Market Cap
Relmada Therapeutics has a market cap or net worth of $326.33 million as of March 6, 2026. Its market cap has increased by 3,335.10% in one year.
Market Cap
326.33M
Enterprise Value
312.45M
1-Year Change
3,335.10%
Ranking
Category
Stock Price
$4.45
Market Cap Chart
Since September 30, 2015, Relmada Therapeutics's market cap has increased from $56.60M to $326.33M, an increase of 476.56%. That is a compound annual growth rate of 18.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 326.30M | -7.88% |
| Dec 31, 2025 | 354.20M | 2,156.05% |
| Dec 31, 2024 | 15.70M | -87.40% |
| Dec 29, 2023 | 124.60M | 18.67% |
| Dec 30, 2022 | 105.00M | -73.42% |
| Dec 31, 2021 | 395.00M | -24.17% |
| Dec 31, 2020 | 520.90M | 30.00% |
| Dec 31, 2019 | 400.70M | 1,125.38% |
| Dec 31, 2018 | 32.70M | 247.87% |
| Dec 29, 2017 | 9.40M | -28.24% |
| Dec 30, 2016 | 13.10M | -54.67% |
| Dec 31, 2015 | 28.90M | -48.94% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Foghorn Therapeutics | 329.52M |
| Adlai Nortye | 329.15M |
| Avalo Therapeutics | 328.23M |
| Opus Genetics | 327.58M |
| Rezolute | 323.56M |
| Puma Biotechnology | 320.52M |
| X4 Pharmaceuticals | 319.14M |
| Immuneering | 318.33M |